Improved survival outcome in SARs-CoV-2 (COVID-19) acute respiratory distress syndrome patients with tocilizumab administration N Wadud, N Ahmed, M Shergil, M Khan, M Krishna, A Gilani, SE Zarif, ... medRxiv, 2020.05. 13.20100081, 2020 | 42 | 2020 |
Improved survival outcome in SARs-CoV-2 (COVID-19) acute respiratory distress syndrome patients with tocilizumab administration. medRxiv [Preprint. Posted: 2020, May 16] N Wadud, N Ahmed, MM Shergil, M Khan, MG Krishna, A Gilani, S El Zarif, ... DOI 10 (2020.05), 13.20100081, 0 | 7 | |
Mayo clinic critical and neurocritical care board review EFM Wijdicks, JY Findlay, WD Freeman, MD Ayan Sen Oxford University Press, 2019 | 4 | 2019 |
Pulmonary vein stenosis mimicking nonspecific interstitial pneumonia KR Linga, A Khoor, JA Phelan, I Mira-Avendano Case Reports in Pulmonology 2015, 2015 | 4 | 2015 |
Improved survival outcome in patients with SARS-COV-2 (COVID-19) ARDS with tocilizumab administration N Wadud, N Ahmed, M Shergill, M Khan, M Krishna, A Gilani, S El Zarif, ... Chest 158 (4), A696-A697, 2020 | 3 | 2020 |
A53 INFECTIOUS DISEASES CASE REPORTS II: Pneumonia, Rhabdomyolysis And Acute Renal Failure-A Deadly Cocktail! KR Linga, DB Deo American Journal of Respiratory and Critical Care Medicine 189, 1, 2014 | 3 | 2014 |
Efficacy of novel synthetic angiotensin II in septic shock I Pak, M Chaudhry, L Stuczynski, K Linga, M Krishna Chest 158 (4), A699, 2020 | 2 | 2020 |
153: OUTCOMES AMONG INTUBATED AND NONINTUBATED COVID-19-POSITIVE AND INTUBATED COVID-19-NEGATIVE PATIENTS N Wadud, N Ahmed, M Shergill, M Khan, M Krishna, A Gilani, S El Zarif, ... Critical Care Medicine 50 (1), 60, 2022 | 1 | 2022 |
CLINICAL OUTCOMES, COMPARISON, AND CHARACTERISTICS AMONG PATIENTS WHO WERE INTUBATED, NONINTUBATED COVID-19 POSITIVE AND INTUBATED COVID-19 NEGATIVE: SINGLE CENTER … N Wadud, N Ahmed, M Shergill, M Khan, M Krishna, A Gilani, S El Zarif, ... Chest 160 (4), A1015-A1016, 2021 | | 2021 |
Clinical Characteristics and Outcomes Comparison Amongst COVID-19 Positive Intubated, Non-Intubated and COVID-19 Negative Intubated Patients; Single Center, Retrospective Study N Wadud, N Ahmed, M Shergill, M Khan, M Krishna, A Gilani, S El Zarif, ... TP49. TP049 COVID: ARDS AND ICU MANAGEMENT, A2552-A2552, 2021 | | 2021 |
151: Does Tocilizumab Improve Survival Outcome in COVID-19 Acute Respiratory Distress Syndrome Patients? N Wadud, N Ahmed, M Shergill, M Khan, M Krishna, A Gilani, S El Zarif, ... Critical Care Medicine 49 (1), 61, 2021 | | 2021 |
537: YOUR COLON IS CLEAN, SORRY ABOUT YOUR SPLEEN M Tatari, R Bryde, J Blanco, K Linga, P Guru Critical Care Medicine 46 (1), 254, 2018 | | 2018 |
Pulmonary Alveolar Proteinosis After Exposure to Cleaning Fluids K Linga, M Kwon, B Colaco, V Arunthari, N Patel Chest 152 (4), A254, 2017 | | 2017 |
An Unusual Differential for Intractable Cough and Hoarseness: Tracheocele K Linga, M Kwon, V Arunthari, B Colaco, J Pascual Chest 152 (4), A743, 2017 | | 2017 |
Malignant Mesothelioma-Novel Approach To Pleural Sampling K Linga, V Gomez, JP Leventhal C46. PLEURAL DISEASE: CASE REPORTS II, A5646-A5646, 2017 | | 2017 |
Retrospective Analysis Of Twelve Patients With Anti-Synthetase Syndrome-Mayo Clinic Experience K Linga, SW Robison, A Lee, I Mira-Avendano A42. AUTOIMMUNE MYOSITIS, ANTISYNTHETASE, SCLERODERMA, AND IPAF, A1540-A1540, 2016 | | 2016 |
A42 AUTOIMMUNE MYOSITIS, ANTISYNTHETASE, SCLERODERMA, AND IPAF: Retrospective Analysis Of Twelve Patients With Anti-Synthetase Syndrome-Mayo Clinic Experience K Linga, SW Robison, A Lee, I Mira-Avendano American Journal of Respiratory and Critical Care Medicine 193, 1, 2016 | | 2016 |
Outcome of pts with chronic lymphocytic leukemia (CLL) with abnormal pulmonary radiologic findings. H Al-Sharif, A Anand, K Linga, A Al-Ameri Journal of Clinical Oncology 32 (15_suppl), e18011-e18011, 2014 | | 2014 |
Outcome of patients with multiple myeloma (MM) requiring intensive care unit: Single center experience. A Anand, K Linga, H Al-Sharif, A Al-Ameri Journal of Clinical Oncology 32 (15_suppl), e19570-e19570, 2014 | | 2014 |
Outcome of pts with acute myelocytic leukemia (AML) and high-risk myelodysplastic syndrome (MDS) with abnormal pulmonary radiologic findings. H Al-Sharif, A Anand, K Linga, A Al-Ameri Journal of Clinical Oncology 32 (15_suppl), e18013-e18013, 2014 | | 2014 |